FDA Wise To Duck High Court Off-Label Ruling, Attys Say
The U.S. Food and Drug Administration has decided not to challenge the Second Circuit's decision that a sales representative's truthful off-label promotion of a drug was protected speech, a move experts...To view the full article, register now.
Already a subscriber? Click here to view full article